Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer
Foyez Mahmud, Shanshan Deng, Hao Chen, Duane D. Miller, Wěi Li
Topics & Concepts
PaclitaxelTaxaneLung cancerA549 cellPharmacologyCancer researchIn vivoCancer cellApoptosisCancerMedicineBiologyInternal medicineBiochemistryBreast cancerBiotechnologyCancer therapeutics and mechanismsDrug Transport and Resistance MechanismsCancer Mechanisms and Therapy